CATALOGO DEI PRODOTTI DELLA RICERCA

CRISAFULLI, Ernesto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.553
EU - Europa 4.752
AS - Asia 3.805
SA - Sud America 622
AF - Africa 96
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 8
Totale 14.850
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.449
RU - Federazione Russa 2.276
SG - Singapore 1.816
IT - Italia 931
CN - Cina 715
BR - Brasile 490
HK - Hong Kong 438
VN - Vietnam 382
FR - Francia 371
IE - Irlanda 310
DE - Germania 256
GB - Regno Unito 140
SE - Svezia 129
KR - Corea 128
NL - Olanda 92
FI - Finlandia 73
IN - India 67
AR - Argentina 65
CA - Canada 50
BD - Bangladesh 36
ID - Indonesia 34
IQ - Iraq 31
JP - Giappone 29
MX - Messico 28
PL - Polonia 28
ES - Italia 27
TR - Turchia 24
BE - Belgio 21
BJ - Benin 19
UA - Ucraina 19
ZA - Sudafrica 19
EC - Ecuador 17
NG - Nigeria 17
CL - Cile 15
PK - Pakistan 15
LT - Lituania 12
CO - Colombia 11
SA - Arabia Saudita 11
AT - Austria 10
EU - Europa 10
PH - Filippine 10
TG - Togo 10
UZ - Uzbekistan 10
JO - Giordania 9
VE - Venezuela 9
MY - Malesia 8
AE - Emirati Arabi Uniti 7
KE - Kenya 7
PY - Paraguay 7
CZ - Repubblica Ceca 6
JM - Giamaica 6
MA - Marocco 6
AL - Albania 5
AU - Australia 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
EG - Egitto 5
RO - Romania 5
BH - Bahrain 4
BY - Bielorussia 4
KZ - Kazakistan 4
LB - Libano 4
LV - Lettonia 4
NO - Norvegia 4
NP - Nepal 4
TN - Tunisia 4
UY - Uruguay 4
AZ - Azerbaigian 3
BG - Bulgaria 3
CH - Svizzera 3
CR - Costa Rica 3
HN - Honduras 3
HR - Croazia 3
HU - Ungheria 3
IR - Iran 3
MT - Malta 3
PT - Portogallo 3
SI - Slovenia 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
DK - Danimarca 2
GT - Guatemala 2
IL - Israele 2
NC - Nuova Caledonia 2
OM - Oman 2
RS - Serbia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BZ - Belize 1
CU - Cuba 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
GY - Guiana 1
IM - Isola di Man 1
Totale 14.840
Salva come PNG Salva come JPEG
Città #
Dallas 1.220
Singapore 860
Ashburn 817
Moscow 761
San Jose 711
Chandler 476
Hong Kong 436
Dublin 305
Verona 238
The Dalles 193
Jacksonville 184
Ho Chi Minh City 130
Beijing 112
Lawrence 108
Princeton 108
Sindelfingen 100
Los Angeles 97
Seattle 86
Wilmington 84
New York 81
Hanoi 75
Redondo Beach 70
Buffalo 57
São Paulo 51
Council Bluffs 47
Rome 47
Columbus 43
Boardman 39
Milan 39
Munich 39
London 36
Redmond 35
Frankfurt am Main 34
Helsinki 34
Santa Clara 31
Tokyo 27
Bologna 26
Xi'an 26
Ann Arbor 25
Turku 25
Falkenstein 24
Southend 24
Haiphong 23
Norwalk 23
Orem 23
Warsaw 23
Tianjin 21
Cotonou 19
Amsterdam 18
Nuremberg 18
Abuja 17
Brussels 17
Chicago 17
Da Nang 17
Denver 17
Guangzhou 17
Dongguan 16
Chennai 15
Montreal 15
Rio de Janeiro 15
Jinan 14
Lappeenranta 14
Paris 14
Phoenix 14
Stockholm 14
Toronto 14
Poplar 13
San Francisco 13
City of London 12
Falls Church 12
Baghdad 11
Brooklyn 11
Kent 11
Mexico City 11
Turin 11
Ankara 10
Jakarta 10
Lomé 10
Mumbai 10
Nanjing 10
New Delhi 10
Amman 9
Atlanta 9
Biên Hòa 9
Boston 9
Curitiba 9
Hangzhou 9
Johannesburg 9
Trento 9
Belo Horizonte 8
Fairfield 8
Fortaleza 8
Manchester 8
Seoul 8
Tashkent 8
Trieste 8
Bari 7
Brasília 7
Bắc Ninh 7
Cesena 7
Totale 8.697
Salva come PNG Salva come JPEG
Nome #
Polmonite interstiziale con caratteristiche autoimmuni (IPAF) Interstitial pneumonia with autoimmune features (IPAF 632
Glucocorticoid Treatment in Severe COPD Exacerbations: Biological Rationale, Clinical Effects, and Practical Advice 329
Persistence of fatigue in the absence of pathophysiological mechanisms in some patients more than 2 years after the original SARS-CoV-2 infection 278
Role of Non-Invasive Ventilation in Elderly Patients: Therapeutic Opportunity or Medical Futility? An Updated Narrative Review 260
Asthmatic patients in COVID-19 outbreak: Few cases despite many cases 180
Nervous system: subclinical target of SARS-CoV-2 infection 175
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity 175
Exercise prehabilitation in lung cancer: Getting stronger to recover faster 175
Chronic fatigue syndrome: an emerging sequela in COVID-19 survivors? 175
Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve 175
Neurological symptoms and axonal damage in COVID-19 survivors: are there sequelae? 174
Six-minute walk distance in healthy subjects: reference standards from a general population sample 163
Acute exacerbations of COPD: Risk factors for failure and relapse 154
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey 151
Cytomegalovirus-Induced Gastrointestinal Bleeding and Pancreatitis Complicating Severe Covid-19 Pneumonia: A Paradigmatic Case 149
Importance of Cardiopulmonary Exercise Testing amongst Subjects Recovering from COVID-19 149
A pulmonary infection by Actinomyces odontolyticus and Veillonella atypica in an immunocompetent patient with dental caries 146
Impact of the Visceral Adipose Tissue on Bone Quality in Patients with Untreated mild-to-severe Obstructive Sleep Apnoea 145
Residual Lung Function Impairment Is Associated with Hyperventilation in Patients Recovered from Hospitalised COVID-19: A Cross-Sectional Study 143
Bone Mineral Density in Mountain, Road Cyclists and Untrained Controls: Exercise, Diet and Hormones 138
Impact of sex on circulating leukocytes composition in COPD patients 138
Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase 136
Efficacy of temporary positive expiratory pressure (TPEP) in patients with lung diseases and chronic mucus hypersecretion. The UNIKO® project: a multicentre randomized controlled trial 128
Beyond diagnosis: a narrative review of the evolving therapeutic role of medical thoracoscopy in the management of pleural diseases 124
A High Degree of Dyspnea Is Associated With a Poor Maximum Exercise Capacity in Subjects With COPD With the Same Severity of Air-Flow Obstruction 124
Baseline Exercise Tolerance and Perceived Dyspnea to Identify the Ideal Candidate to Pulmonary Rehabilitation: A Risk Chart in COPD Patients 123
Persisting exercise ventilatory inefficiency in subjects recovering from COVID-19. Longitudinal data analysis 34 months post-discharge 122
Metabolic-associated fatty liver disease and liver fibrosis scores as COVID-19 outcome predictors: a machine-learning application 122
Circulating eosinophil levels and lung function decline in stable chronic obstructive pulmonary disease: a retrospective longitudinal study 122
Age is a determinant of short-term mortality in patients hospitalized for an acute exacerbation of COPD 122
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI) 122
Assessment of severity of ICU-acquired pneumonia and association with etiology 120
Are interstitial lung abnormalities associated with COPD? A nested case–control study 119
Asymptomatic peripheral artery disease can limit maximal exercise capacity in chronic obstructive pulmonary disease patients regardless of airflow obstruction and lung hyperinflation 119
Aerobic Intermittent Hypoxic Training Is Not Beneficial for Maximal Oxygen Uptake and Performance: A Systematic Review and Meta-Analysis 118
Short-term efficacy of upper-extremity exercise training in patients with chronic airway obstruction: A systematic review 118
Exercise ventilatory inefficiency may be a relevant CPET-feature in COVID-19 survivors 117
The Caliber of Segmental and Subsegmental Vessels in COVID-19 Pneumonia Is Enlarged: A Distinctive Feature in Comparison with Other Forms of Inflammatory and Thromboembolic Diseases 116
A shadow in the GOLD ABCD classification system: measurement of perception of symptoms in COPD 116
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 114
A Practical Approach to Pneumothorax Management 112
Activity and analysis of costs in a dedicated weaning centre 111
Relevance of Smoking Habit in Severe Asthma Patients: Evidence from the Severe Asthma Network in Italy (SANI) Registry 110
Anthropometry in Special and Selective Conditions and Circumstances: Anthropometry as Measure of Risk in COPD Patients 110
C-reactive protein at discharge, diabetes mellitus and ≥1 hospitalization during previous year predict early readmission in patients with acute exacerbation of chronic obstructive pulmonary disease 108
Association between persistent dyspnea and psychological distress in COVID-19 survivors. A cross-sectional evaluation at 11 months after hospitalization 106
Feasibility and effectiveness of an educational program in Italian COPD patients undergoing rehabilitation 106
Clinical risk scores for the early prediction of severe outcomes in patients hospitalized for COVID-19 106
Systemic Inflammatory Response and Outcomes in Community-Acquired Pneumonia Patients Categorized According to the Smoking Habit or Presence of Chronic Obstructive Pulmonary Disease 104
Association Between Rome Classification Among Hospitalized Patients With COPD Exacerbations and Short-Term and Intermediate-Term Outcomes 100
Effect of α1 Antitrypsin Deficiency on Lung Volume Decline in Severe Asthmatic Patients Undergoing Biologic Therapy 99
Endotracheal tubes for critically ill patients: An in vivo analysis of associated tracheal injury , mucociliary clearance, and sealing effi cacy 98
null 96
Relationships between emphysema and airways metrics at High-Resolution Computed Tomography (HRCT) and ventilatory response to exercise in mild to moderate COPD patients 94
Management of severe acute exacerbations of COPD: an updated narrative review 93
Aetiological diagnosis in new adult outpatients with bronchiectasis:role of predictors derived from real life experience 92
Exploring the efficacy and advancements of medical pleurodesis: a comprehensive review of current research 91
Effects of unsupported upper extremity exercise training in patients with COPD: A randomized clinical trial 91
Factors associated with risk of death in hospitalized patients for exacerbation of chronic obstructive pulmonary disease: an updated scoping review 90
Do Patients with Bronchiectasis Have an Increased Risk of Developing Lung Cancer? A Systematic Review 90
Cost-effectiveness of NIV applied to chronic respiratory failure 89
COPD and the metabolic syndrome: An intriguing association 89
Reducing Hospital Readmissions in Chronic Obstructive Pulmonary Disease Patients: Current Treatments and Preventive Strategies 89
Prevalence of Depression in Sarcoidosis: a comparison with asthmatic and healthy controls 88
Endoscopic Technologies for Peripheral Pulmonary Lesions: From Diagnosis to Therapy 87
Endobronchial ultrasound: a pictorial essay 87
Cough, a vital reflex. mechanisms, determinants and measurements 87
Use of non-invasive respiratory supports in high-intensity internal medicine setting during the first two waves of the COVID-19 pandemic emergency in Italy: a multicenter, real-life experience 87
Rehabilitation in COPD patients admitted for exacerbation 86
Pneumonic versus Nonpneumonic Exacerbations of Chronic Obstructive Pulmonary Disease 86
Autonomic nervous system alterations in patients with mild-to-moderate asthma: do not forget airflow obstruction! a lesson from COPD 85
Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?" 85
Inhaled beclometasone dipropionate/formoterol fumarate extrafine fixed combination for the treatment of asthma 85
Inhaled corticosteroids do not influence the early inflammatory response and clinical presentation of hospitalized subjects with COPD exacerbation 85
Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: A 15-day, prospective, parallel, open-label, pilot study 85
Rehabilitation and supportive therapy in elderly patients with chronic obstructive pulmonary disease 84
Impact of bronchiectasis on outcomes of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease: A propensity matched analysis 83
Clinical variables predicting the risk of a hospital stay for longer than 7 days in patients with severe acute exacerbations of chronic obstructive pulmonary disease: a prospective study 82
Long-term weight loss and maintenance in morbidly obese individuals with obstructive sleep apnea 82
Efficacy of standard rehabilitation in COPD outpatients with comorbidities 82
Learning impact of education during pulmonary rehabilitation program. An observational short-term cohort study 82
The Role of Medical Thoracoscopy with Talc Poudrage in Spontaneous, Iatrogenic, and Traumatic Pneumothorax: A Prolonged Experience of a Tertiary Care Center 81
Home-centred physical fitness programme in morbidly obese individuals: A randomized controlled trial 81
Respiratory muscles training in COPD patients 81
Transthoracic Echocardiography and Chest Computed Tomography Arteriography in Patients with Acute Pulmonary Embolism: A Two-Year Follow-Up Study 80
Systemic inflammatory pattern of patients with community-acquired pneumonia with and without COPD 79
Home non-invasive mechanical ventilation and long-term oxygen therapy in stable hypercapnic chronic obstructive pulmonary disease patients: Comparison of costs 79
Minimum Clinically Important Difference in 30-s Sit-to-Stand Test After Pulmonary Rehabilitation in Subjects With COPD 79
Pleuritis with pleural effusion due to a Bacillus megaterium infection 78
Measures of dyspnea in pulmonary rehabilitation 78
Effects of beclomethasone/formoterol fixed combination on lung hyperinflation and dyspnea in COPD patients 78
Predicting walking-induced oxygen desaturations in COPD patients: A statistical model 78
The role of the microbiome in childhood asthma 78
Prevalence of Small-Airway Dysfunction among COPD Patients with Different GOLD Stages and Its Role in the Impact of Disease 77
COPD 2017: A Year in Review 76
Predicting poor prognosis in COPD patients: Looking for a lamp lit in the darkness of the night 76
Energy expenditure at rest and during walking in patients with chronic respiratory failure: a prospective two-phase case-control study 75
Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study 74
Impact of the visceral adipose tissue on bone quality in patients with untreated mild-to-severe obstructive sleep apnea 74
Series "novelties in pulmonary rehabilitation": Determinants of success 74
Totale 11.784
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.491
article - articoli 51.909
book - libri 0
conference - conferenze 384
curatela - curatele 0
other - altro 231
patent - brevetti 0
selected - selezionate 0
volume - volumi 967
Totale 106.982
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021120 0 0 0 0 0 0 0 0 0 10 93 17
2021/2022581 18 142 4 22 13 20 6 74 30 26 88 138
2022/20231.583 132 115 230 246 130 380 12 104 140 21 42 31
2023/20241.002 47 73 139 141 63 126 48 92 10 40 127 96
2024/20252.767 196 103 79 420 131 126 108 152 431 172 265 584
2025/20268.714 586 365 1.434 1.334 2.026 540 777 552 689 411 0 0
Totale 15.188